πŸ‡ΊπŸ‡Έ FDA
Patent

US 12084659

Modulatory polynucleotides

granted A61PA61P43/00

Quick answer

US patent 12084659 (Modulatory polynucleotides) held by VOYAGER THERAPEUTICS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P43/00